Welcome to our dedicated page for Vicor SEC filings (Ticker: VICR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Vicor Corporation (VICR) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Vicor is a NASDAQ-listed issuer whose common stock is registered under Section 12(b) of the Exchange Act, and its filings give structured insight into the business of designing, developing, manufacturing and marketing modular power components and complete power systems based on patented technologies.
Investors can use this page to review Vicor’s current reports on Form 8-K, which include items such as quarterly earnings announcements and the results of the annual meeting of stockholders. For example, recent 8-K filings reference financial results for periods ended March 31, June 30 and September 30, 2025, and a filing describing matters submitted to a vote of security holders at the 2025 Annual Meeting. These documents also confirm that Vicor’s common stock trades on The NASDAQ Stock Market LLC under the symbol VICR.
In addition to 8-Ks, Vicor’s broader SEC reporting framework includes annual reports on Form 10-K and quarterly reports on Form 10-Q, which the company references in its press releases. These filings contain sections such as “Business,” “Risk Factors,” “Legal Proceedings” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” as well as audited and unaudited financial statements. Together, they outline Vicor’s operations in modular power components and systems, its intellectual property position, and financial details such as product and royalty revenues, margins and cash flows.
The filings page also surfaces proxy and governance-related information, such as disclosures about the annual meeting and the election of directors, as seen in the 8-K describing the 2025 Annual Meeting vote. For users interested in executive and board matters, capital structure, or voting results, these documents provide the official record.
Stock Titan enhances access to these filings with AI-powered summaries that explain key points from lengthy documents, helping users quickly understand what Vicor reports about its financial condition, results of operations, risk factors and corporate actions. Real-time updates from the SEC’s EDGAR system ensure that new VICR filings, including 10-Ks, 10-Qs, 8-Ks and related exhibits, appear promptly, while AI-generated highlights make it easier to interpret complex regulatory language without replacing the need to consult the full filings.
Vicor Corporation reported strong fourth-quarter and full-year 2025 results, highlighted by higher revenue, margins and earnings. Q4 2025 product revenue reached $92.7 million, up 15.3% year over year, while total Q4 net income jumped to $46.5 million, or $1.01 per diluted share, helped by a $27.3 million tax benefit. Q4 gross margin rose to 55.4% of revenue and backlog increased to $176.9 million, up 13.8% from a year earlier.
For 2025, product revenue grew 12.1% to $350.3 million and royalty revenue rose 23.2% to $57.4 million. Including a $45 million patent litigation settlement, total revenue reached $452.7 million and net income surged to $118.6 million, or $2.61 per diluted share, versus $6.1 million a year earlier. Cash and cash equivalents climbed to $402.8 million as of December 31, 2025, supported by $139.5 million in operating cash flow. Management expects rising demand and its IP licensing business to drive record product and licensing revenues in 2026.
JPMorgan Chase & Co. has filed an amended Schedule 13G reporting a significant passive ownership stake in Vicor Corporation. As of 12/31/2025, JPMorgan Chase & Co. is deemed to beneficially own 4,016,883 shares of Vicor common stock, representing 12.1% of the class.
The filing states that JPMorgan Chase & Co. has sole voting power over 2,197,481 shares and shared voting power over 37 shares, with sole dispositive power over 4,013,413 shares and shared dispositive power over 3,469 shares. The certification indicates the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of Vicor.
Vicor Corporation director Andrew D'Amico reported an option exercise and share sale involving a small number of shares. On January 20, 2026, he exercised a non-qualified stock option for 200 shares of Vicor common stock at an exercise price of $100 per share, acquiring 200 shares. The same day, he sold 200 shares of common stock at $155 per share, leaving him with 0 shares of common stock held directly after the reported transactions.
The filing shows that 200 non-qualified stock options remained beneficially owned directly following the derivative transaction. The sale was effected under a Rule 10b5-1 trading plan that the reporting person adopted on September 12, 2024, indicating the trades were made according to a pre-arranged plan rather than discretionary timing.
Vicor Corporation (VICR) insider has filed a Form 144 for a small planned stock sale. The notice covers the proposed sale of 200 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $29,976.00. The shares relate to an issuer with 32,925,914 common shares outstanding and are expected to be sold on or about January 20, 2026 on the NASDAQ.
The 200 shares to be sold were acquired on January 20, 2026 via a cash exercise of stock options. The filing also lists prior Rule 10b5-1 plan sales over the past three months by Andrew Damico, including transactions such as 14,677 shares of common stock sold on October 22, 2025 for gross proceeds of $1,211,253.00, alongside several smaller sales.
Vicor director Samuel J. Anderson exercised stock options and increased his direct shareholdings. On 01/15/2026, he exercised a non‑qualified stock option with a $100 exercise price for 800 shares of Vicor common stock, acquiring 800 shares at $100 per share.
These options were originally granted on 06/25/2021 under the company’s Amended and Restated 2000 Stock Option and Incentive Plan and vest over five years, with an expiration date of 06/25/2031. Following this transaction, Anderson directly holds 9,898 shares of Vicor common stock and 200 non‑qualified stock options.
Vicor Corp director Andrew D'Amico reported an option exercise and related share sale. On 01/15/2026 he exercised a non-qualified stock option for 200 shares of common stock at $100 per share, increasing his directly held common shares to 200 and his option holdings to 400. On the same day, he sold 200 common shares at $150 per share, leaving him with 0 shares of common stock directly owned and 400 non-qualified stock options outstanding. The sale was carried out under a Rule 10b5-1 trading plan adopted on September 12, 2024.
Vicor insider Andrew Damico has filed a Form 144 indicating an intent to sell 200 shares of Vicor common stock. The planned sale, through Morgan Stanley Smith Barney on NASDAQ, has an aggregate market value of $29,064, with 32,925,914 Vicor shares outstanding. The 200 shares were acquired the same day via a cash exercise of stock options.
The notice also lists prior Rule 10b5-1 sales by Damico over the past three months, including 14,677 shares sold on 10/22/2025 for $1,211,253 and several smaller transactions. By signing the form, the insider represents that he is not aware of any undisclosed material adverse information about Vicor.